# Fibrinolysis Compared to Thoracoscopy for Pleural Infection

> **NCT03468933** · PHASE4 · COMPLETED · sponsor: **Tulane University** · enrollment: 32 (actual)

## Conditions studied

- Pleural Infection
- Empyema
- Pleural Diseases
- Parapneumonic Effusion

## Interventions

- **DRUG:** tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase)
- **PROCEDURE:** Medical Thoracoscopy

## Key facts

- **NCT ID:** NCT03468933
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468933, "Fibrinolysis Compared to Thoracoscopy for Pleural Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03468933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*